Method for treatment for neuro-muscular incontinence
US5130336A · kind A · utility
0Cited by
0References
16Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Nov 15, 1991 |
| Grant date | Jul 14, 1992 |
| Priority date | — |
| Expiry date | Nov 15, 2011 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P21/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Treating a patient for neuro-muscular incontinence by administering a thiol-S-(2-diethyl-aminoethyl)-ester compound selected from the group consisting of trimethylacetyl-thio-S-(2-diethylaminoethyl)-ester, 1-cyclohexyl-1-phenylacetyl-thiol-S-(2-diethylaminoethyl)-ester, palmitoyl-thio-S-(2-diethylaminoethyl)-ester, 4-t-butyl-benzoyl-thiol-S-(2-diethylaminoethyl)-ester, phenylacetyl-thio-S-(2-diethylaminoethyl)-ester, 4-phenyl-butyryl-thio-S-(2-diethylaminoethyl)-ester, and 2-ethyl-butyryl-thio-S-(2-diethylaminoethyl)-ester.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.